Additional file 4 of Statistical analysis plan for the Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high-grade serous type, and carcinosarcoma) trial (DICE)
- Resource Type
- Authors
- de la Rosa, Consuelo N��hpal; Krell, Jonathan; Day, Emily; Clarke, Aaron; Reddi, Meena; Webber, Lee; Fiorentino, Francesca
- Source
- Subject
- Language
Additional file 4: Supplement 1: Tables. Table 1: Schedule of Assessments for Screening. Table 2: Schedule of Assessments for: Weekly Paclitaxel alone. Table 3: Schedule of Assessments for Weekly Paclitaxel plus TAK228. Table 4: Baseline Characteristic Variables. Table 5: Laboratory parameters. Table 6: Listing of ���Most Common��� Adverse Events.